Allergic Rhinitis Treatment Market Growth Accelerated by Rise in Autoimmune Diseases

Allergic Rhinitis Treatment Market
Allergic rhinitis, commonly known as hay fever, is an inflammation of the nasal passages caused by an Immunoglobulin E (IgE) immune response to indoor and outdoor allergens such as dust, mold spores, animal dander, and pollen. Symptoms include sneezing, nasal congestion, nasal itching, and runny nose. Antihistamines, corticosteroid nasal sprays, and immunotherapy treatment help provide relief from symptoms.
The global allergic rhinitis treatment market
size is estimated to be valued at US$ 20.94 billion in 2024 and is expected to
exhibit a CAGR of 9.0% over the forecast period 2024 to 2031, as highlighted in
a new report published by Coherent Market Insights.
Market key trends:
The rising prevalence of autoimmune disorders is expected to drive the growth
of the market during the forecast period. According to a study published in the
Journal of Clinical and Translational Science in 2020, the prevalence of
autoimmune disorders has increased globally over past few decades. Furthermore,
genetic and environmental factors such as pollution, smoking, dietary changes,
geographic location, and lifestyle patterns are contributing to the development
of autoimmune conditions. Thus, the increasing incidence of autoimmune diseases
including allergic rhinitis is anticipated to boost the demand for allergic
rhinitis treatment drugs and devices over the forecast period.
Segment
Analysis
Intranasal corticosteroids is the dominating sub-segment in the allergic
rhinitis treatment market. It holds around 45% share owing to its effectiveness
in treating symptoms of nasal inflammation, congestion and reducing recurrence
rate of allergic rhinitis. Intranasal corticosteroids are also effective
without the side effects of oral corticosteroids.
Key Takeaways
The Global
Allergic Rhinitis Treatment Market Size is expected to witness high
growth during the forecast period owing to rising pollution levels, increasing
prevalence of allergic diseases and growing older population.
Regional analysis: North America dominated the global allergic rhinitis
treatment market in 2023 and is expected to continue its dominance during the
forecast period as well. This is attributed to high healthcare expenditure,
growing medical tourism, rising pollution and presence of advanced healthcare
facilities in the region. Asia Pacific is expected to witness fastest growth in
the market due to rising awareness regarding treatment of allergic diseases,
growing spending on healthcare and increasing pollution levels with growing
industrialization.
Key players: Key players operating in the allergic rhinitis treatment market
are ABB, Emerson Electric Co., Honeywell International, Inc., Kawasaki Heavy
Industries, Ltd., Mitsubishi Electric Corporation, OMRON Corporation, Rockwell
Automation, Inc., and Schneider Electric.
For more Insights, Read –
https://www.marketwebjournal.com/allergic-rhinitis-treatment-market-size-market-share-analysis/
Comments
Post a Comment